Clinical Trial: Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Randomized Controlled Trail At 6 Years

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757373) titled 'Romosozumab Versus Denosumab In Glucocorticoid-induced Osteoporosis: An Extended Observation Of a Randomized Controlled Trail At 6 Years' on July 19.

Brief Summary: This is an extended observation study of a RCT comparing the efficacy of romorozumab and denosumab in high-risk patients using long-term glucocorticoids. In the romosozumab arm, patients were shifted to denosumab after the first year. The denosumab arm of patients were continued on denosumab. This study aims to look at the bone mineral density changes in both groups of patients after 6 years.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Glucocorti...